Home | Welcome to Contract Pharma   
Last Updated Saturday, April 25 2015

Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

By Kristin Brooks
Published February 12, 2014
Kile brings 27 years of industry experience Read More »
Published May 7, 2013
Wierman to lead oncology efforts Read More »
Published January 2, 2013
Resumes Abbott’s research-based business Read More »
Published February 3, 2012
Will initially produce clinical batches for eight clinical trial sites Read More »
By Gil Roth
Published January 17, 2012
Will work on DNA minor groove binder Read More »
Published August 18, 2011
Commercial sale of Phoslyra triggers $5M payment Read More »
Building Agility into Pharma and Biopharma
By Chris Driscoll
Published September 3, 2009
Learning lessons from other industries Read More »
Biopharma CMO Market Report
By William Downey
Published May 1, 2009
Optimism remains high among bio-contract manufacturers Read More »
Published August 20, 2008
Bristol-Myers Squibb and PDL BioPharma, Inc. entered an agreement for the global development and commercialization of PDL’s anti-CS1 antibody, elotuzumab, currently in Phase I development for multiple myeloma.     Elotuzumab o… Read More »
Biopharma CMO Market Report
By William Downey
Published April 30, 2008
Optimism is high among bio-contract manufacturers Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On